X-inactivation informs variance-based testing for X-linked association of a quantitative trait

BMC Genomics

Volumn 16, Issue 1, 2015, Pages

  Ma, Li ^a,b   Hoffman, Gabriel ^b,c   Keinan, Alon ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b Program on Infrastructure Policy   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFF2 GENE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHROMOSOME ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOMOZYGOSITY; MEASUREMENT ERROR; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; SIGNAL PROCESSING; X CHROMOSOME INACTIVATION; ALGORITHM; ALLELE; ATHEROSCLEROSIS; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HETEROZYGOTE; HUMAN; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOMAL INHERITANCE;

ALGORITHMS; ALLELES; ATHEROSCLEROSIS; FEMALE; GENES, X-LINKED; GENOME-WIDE ASSOCIATION STUDY; HETEROZYGOTE; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; X CHROMOSOME INACTIVATION;

EID: 84925875500     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-1463-y     Document Type: Article

References (44)

1. Whitacre CC. Sex differences in autoimmune disease. Nature immunology 2. 2001;9:777-80.
2. Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, et al. Sex differences in the management of coronary artery disease. N Engl J Med. 1991;325(4):226-30.
3. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434(7031):400-4.
4. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008;9(12):911-22.
5. Choi BG, McLaughlin MA. Why men's hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am. 2007;36(2):365-77.
6. Postma DS. Gender differences in asthma development and progression. Gend Med. 2007;4:S133-46.
7. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777-80.
8. Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the world health organization collaborative study on psychological problems in general health care. Arch Gen Psychiatry. 1998;55(5):405-13.
9. Matanoski G, Tao XG, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer. 2006;107(S5):1112-20.
10. Leger PD, Johnson DH, Robbins GK, Shafer RW, Clifford DB, Li J, et al. Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS clinical trials group protocol 384. J Neurovirol. 2014;20(3):304-8.
11. Yang B, Mo Z, Wu C, Yang H, Yang X, He Y, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics. 2014;7(1):10.
12. Zheng G, Joo J, Zhang C, Geller NL. Testing association for markers on the X chromosome. Genet Epidemiol. 2007;31(8):834-43.
13. Clayton D. Testing for association on the X chromosome. Biostatistics. 2008;9(4):593-600.
14. Clayton DG. Sex chromosomes and genetic association studies. Genome Med. 2009;1(11):110.
15. Loley C, Ziegler A, König IR. Association tests for X-chromosomal markers-a comparison of different test statistics. Hum Hered. 2011;71(1):23-36.
16. Wang J, Yu R, Shete S. Xchromosome genetic association test accounting for Xinactivation, skewed Xinactivation, and escape from Xinactivation. Genet Epidemiol. 2014;38(6):483-93.
17. Chang D, Gao F, Ma L, Sams AJ, Slavney A, Waldman YY, et al. Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One. 2014;9(12):e113684.
18. Wise AL, Gyi L, Manolio TA. eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am J Hum Genet. 2013;92(5):643-7.
19. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707-13.
20. Keinan A, Mullikin JC, Patterson N, Reich D. Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans. Nat Genet. 2007;39(10):1251-5.
21. Keinan A, Mullikin JC, Patterson N, Reich D. Accelerated genetic drift on chromosome X during the human dispersal out of Africa. Nat Genet. 2008;41(1):66-70.
22. Gottipati S, Arbiza L, Siepel A, Clark AG, Keinan A. Analyses of X-linked and autosomal genetic variation in population-scale whole genome sequencing. Nat Genet. 2011;43(8):741-3.
23. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Gibbs RA, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-73.
24. Morey C, Avner P. The demoiselle of x-inactivation: 50 years old and as trendy and mesmerising as ever. PLoS Genet. 2011;7(7):e1002212.
25. Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker. Proc Natl Acad Sci U S A. 1962;48:9-16.
26. Russell LB. Mammalian X-chromosome action: inactivation limited in spread and region of origin. Science. 1963;140:976-8.
27. Brown CJ, Lafreniere RG, Powers VE, Sebastio G, Ballabio A, Pettigrew AL, et al. Localization of the X inactivation centre on the human X chromosome in Xq13. Nature. 1991;349(6304):82-4.
28. Tukiainen T, Pirinen M, Sarin A-P, Ladenvall C, Kettunen J, Lehtimäki T, et al. Chromosome X-wide association study identifies loci for fasting insulin and height and evidence for incomplete dosage compensation. PLoS Genet. 2014;10(2):e1004127.
29. Lyon MF. Gene action in the X-chromosome of the mouse (Mus musculus L.). Landmarks Med Genets: Classic Papers with Commentaries. 2004;51:226.
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75.
31. Brown AA, Buil A, Viñuela A, Lappalainen T, Zheng HF, Richards JB, et al. Genetic interactions affecting human gene expression identified by variance association mapping. Elife. 2014;3:e01381.
32. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, et al. Genetic analysis of genome-wide variation in human gene expression. Nature. 2004;430(7001):743-7.
33. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature. 2012;490(7419):267-72.
34. Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. J Comput Biol. 2000;7(6):819-37.
35. Bar HY, Booth JG, Wells MT. A mixture-model approach for parallel testing for unequal variances. Stat Appl Genet Mol Biol. 2012;11(1):1-21.
36. Cao Y, Wei P, Bailey M, Kauwe JS, Maxwell TJ. A versatile omnibus test for detecting mean and variance heterogeneity. Genet Epidemiol. 2014;38(1):51-9.
37. Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH, et al. Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index. PLoS Genet. 2014;10(7):e1004508.
38. Brown MB, Forsythe AB. Robust tests for the equality of variances. J Am Stat Assoc. 1974;69(346):364-7.
39. Weisberg S. Applied linear regression. Vol. 528. New York: John Wiley & Sons; 2005.
40. Williams OD. The Atherosclerosis Risk in Communities (ARIC) study - design and objectives. Am J Epidemiol. 1989;129(4):687-702.
41. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang S-J, et al. Framingham heart study 100 K project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet. 2007;8 Suppl 1:S3.
42. Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, et al. FRAXEassociated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Res. 2009;37:1269-79.
43. Bowie LJ, Reddy PL, Beck KR. Alpha thalassemia and its impact on other clinical conditions. Clin Lab Med. 1997;17(1):97-108.
44. Zaitlen N, Paşaniuc B, Patterson N, Pollack S, Voight B, Groop L, et al. Analysis of case-control association studies with known risk variants. Bioinformatics. 2012;28(13):1729-37.